GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nanologica AB (publ) NICA.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.17

-1.18%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 21.1m

FY2016FY2025

Net income

−SEK 51.3m

FY2016FY2025

Free cash flow

−SEK 40.9m

FY2016FY2025

Shareholders' equity

SEK 22.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 21.1mSEK 14.5mSEK 1.4mSEK 1.6mSEK 12.9mSEK 16.1mSEK 10.2mSEK 4.1mSEK 2.6mSEK 2.0m
Research and development——SEK 7.3mSEK 4.1mSEK 3.8mSEK 2.6mSEK 2.5mSEK 2.7mSEK 2.6m—
Operating income−SEK 47.0m−SEK 59.3m−SEK 70.0m−SEK 50.2m−SEK 41.6m−SEK 18.7m−SEK 19.6m−SEK 21.3m−SEK 19.3m−SEK 22.2m
Net income−SEK 51.3m−SEK 65.6m−SEK 75.2m−SEK 55.1m−SEK 50.1m−SEK 24.8m−SEK 21.5m−SEK 20.9m−SEK 20.1m−SEK 22.5m
Diluted earnings per share-0.58-1.40-2.05-1.52-1.78-0.89-1.25-1.26-4.19-4.68

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 88.1mSEK 143.1mSEK 77.4mSEK 154.5mSEK 98.3mSEK 146.3mSEK 42.3mSEK 34.3mSEK 25.9mSEK 31.9m
Cash and short-term investmentsSEK 3.5mSEK 48.4mSEK 10.1mSEK 70.3mSEK 11.7mSEK 68.0mSEK 1.1mSEK 21.8mSEK 7.0mSEK 16.8m
Total liabilitiesSEK 65.5mSEK 69.0mSEK 79.3mSEK 81.4mSEK 46.7mSEK 53.4mSEK 38.2mSEK 10.6mSEK 24.0mSEK 9.8m
DebtSEK 21.5mSEK 50.9mSEK 666,000SEK 4.7mSEK 9.8mSEK 13.0mSEK 9.1mSEK 4.7mSEK 19.9mSEK 4.6m
Shareholders' equitySEK 22.6mSEK 74.1m−SEK 1.9mSEK 73.2mSEK 51.6mSEK 93.0mSEK 4.1mSEK 23.7mSEK 1.9mSEK 22.0m
Shares outstanding88m47m37m36m28m28m17m17m5m5m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 39.9m−SEK 80.7m−SEK 35.8m−SEK 45.2m−SEK 46.5m−SEK 43.3m−SEK 11.5m−SEK 11.7m−SEK 23.2m−SEK 23.2m
Capital spending−SEK 999,000−SEK 742,000−SEK 21.0m−SEK 8.6m−SEK 7.2m−SEK 6.5m−SEK 31.0m−SEK 3.0m−SEK 1.9m−SEK 2.5m
Free cash flow−SEK 40.9m−SEK 81.5m−SEK 56.8m−SEK 53.8m−SEK 53.7m−SEK 49.9m−SEK 42.5m−SEK 14.7m−SEK 25.1m−SEK 25.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 24.3mSEK 21.5mSEK 5.2mSEK 2.8mSEK 2.3mSEK 10.8mSEK 6.7mSEK 611,000
Operating income−SEK 18.3m−SEK 9.9m−SEK 15.7m−SEK 10.1m−SEK 10.8m−SEK 9.2m−SEK 11.9m−SEK 22.2m
Net income−SEK 18.7mSEK 65.2m−SEK 16.7m−SEK 11.0m−SEK 12.3m−SEK 10.2m−SEK 14.0m−SEK 23.7m
Diluted earnings per share-0.060.22-0.19-0.12-0.14-0.12-0.30-0.51
Cash from operations−SEK 30.0m−SEK 6.0m−SEK 9.0m−SEK 10.0m—−SEK 19.0m−SEK 24.0m−SEK 24.0m
Total assetsSEK 243.6mSEK 262.3mSEK 88.1mSEK 101.3mSEK 112.6mSEK 125.1mSEK 143.1mSEK 95.1m
Cash and short-term investmentsSEK 19.1mSEK 39.3mSEK 3.5mSEK 14.0mSEK 26.4mSEK 28.3mSEK 48.4mSEK 4.1m
DebtSEK 10.4mSEK 73.7mSEK 21.3mSEK 19.5mSEK 6.5mSEK 7.2mSEK 50.7mSEK 3.5m
Shareholders' equitySEK 156.4mSEK 97.5mSEK 22.6mSEK 40.5mSEK 51.6mSEK 63.9mSEK 74.1m−SEK 8.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue138.6%5.5%20.5%
Operating income-2.2%20.2%12.8%
Net income-2.4%15.6%13.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-297.9%-585.7%-423.5%-426.2%
Net margin-327.8%-639.3%-475.7%-468.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-0.5-0.5-1.1-1.4-1.6-3.2-1.8-0.5-0.4-0.7
Price to sales1.22.256.649.96.45.03.82.73.48.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.